Abstract
BCR-ABL1 Transcript Doubling Time after Imatinib Discontinuation for Treatment-Free Remission in Chronic Myeloid Leukemia in Chronic Phase: Predictor for Treatment-Free Remission Failure
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have